A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 425-428

  DeCesare, Steven L ^a,c   Fiorica, James V ^b   Roberts, William S ^b   Reintgen, Douglas ^b   Arango, Hector ^b   Hoffman, Mitchel S ^b   Puleo, Chris ^b   Cavanagh, Denis ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Sacred Heart Hospital Pensacola   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; INTRAOPERATIVE PERIOD; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VULVA CANCER; VULVECTOMY;

EID: 0031240048     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4798     Document Type: Article

References (26)

1. 1. Boyce J, Fruchter RG, Kasambilides E, Nicastri AD, Sedlis A, Remy JC: Prognostic factors in carcinoma of the vulva. Gynecol Oncol 20:364-377, 1985
2. 2. Curry SL, Wharton JT, Rutledge F: Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol 9:63-67, 1980
3. 3. Ericksson E, Eldh J, Peterson LE: Surgical treatment of carcinoma of the clitoris. Gynecol Oncol 17:291-295, 1984
4. 4. Malfetano J, Piver MS, Tsukada Y: Stage III and IV squamous cell carcinoma of the vulva. Gynecol Oncol 23:192-198, 1986
5. 5. Morley GW: Cancer of the vulva: a review. Cancer 48:597-601, 1981
6. 6. Shimm DS, Fuller AF, Orlow EL, Dosoretz DE, Aristizabal SA: Prognostic variables in the treatment of squamous cell carcinoma of the vulva. Gynecol Oncol 24:343-358, 1986
7. 7. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG: Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61:408-412, 1983
8. 8. Podratz KC, Symmonds RE, Taylor WF: Carcinoma of the vulva: analysis of treatment failures. Am J Obstet Gynecol 143:340-351, 1982
9. 9. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LG, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
10. 10. Morton DL, Wen DR, Cochran AJ: Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait". Surg Oncol Clin North Am 1:247-259, 1992
11. 11. Reintgen D, Albertini J, Miliotes G, Berman C, Cruse CW, Fenske N, Glass F, Puleo C, Wang X, Wells K, Rappaport D, Deconti R, Messina J, Heller R: The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Con 4:183-197, 1995
12. 12. Levenback C, Burke TW, Morris M, Malpica A, Lucas K, Gershenson D: Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 59:216-220, 1995
13. 13. Levenback C, Burke TW, Gershenson D, Morris M, Malpica A, Ross MI: Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol Pathol Surg Oncol 84(2):163-167, 1994
14. 14. Barton DPJ, Berman C, Cavanagh D, Roberts WS, Hoffman MS, Fiorica JV: Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol 46:341-344, 1992
15. 15. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rappaport D, Seigler HF, Balch C: The orderly progression of melanoma nodal metastases. Ann Surg 220(6):759-767, 1994
16. 99mTc-colloid (abstract). Netherlands Cancer Institute, Amsterdam. European Society of Surgical Oncology, Heidelberg, Germany, 1994
17. 99mTc sulfur colloid and the Neoprobe 1000 intraoperative detector (abstract). Ohio State University, Neoprobe Co. Society of Nuclear Medicine Meeting, Minneapolis, MN, 1995
18. 18. Panday RKLB, Liem LH, Rutgers EJTh, Muller SH, Hoefnagel CA, Kroon BBR, Balm AJM, Mooi WJ, Nieweg OE: Intra-operative sentinel node (S.N.) identification using gamma detection probe in patients with melanoma (abstract). European Association of Nuclear Medicine Congress, Dusseldorf, Germany, August 1994
19. 19. Krag DN, Meijer SJ, Weaver DL, Loggic BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1998
20. 20. Albertini J, Cruse W, Rappaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass F, Reintgen D: Identification of the sentinel lymph node in melanoma patients using intra-operative radiolymphoscintigraphy (abstract). Cutaneous Oncology Program, Moffitt Cancer Center, University of South Florida, Tampa. Nuclear Oncology: Advances in Diagnostic and Therapeutic Applications, Key Biscayne, FL, 1995
21. 21. Albertin J, Miliotes G, Berman C, Jared K, Messina J, Lyman G, Cruse W, Rappaport D, Glass F, Reintgen D: The accurate staging of the melanoma patient for the identification of the sentinel node (abstract). Cutaneous Oncology Program, Moffitt Cancer Center, University of South Florida, Tampa. Nuclear Oncology: Advances in Diagnostic and Therapeutic Applications, Key Biscayne, FL, 1995
22. 22. Kapteijn BAE, Valdes Olmos RA, Baidjnath RKL, Liem IH, Hoefnagel CA, Kroon BBR, Nieweg OE: Reproducibility of lymphoscintigraphy to identify the first draining lymph node in clinically localized melanoma of the skin (abstract). Netherlands Cancer Institute, Netherlands. Society of Nuclear Medicine Annual Meeting, Minneapolis, MN, 1995
23. 23. Kapteijn BAE, Baidjnath Panday RKL, Liem IH, Rutgers EJTh, Muller SH, Balm AJM, Hoefnagel CA, Kroon BBR, Nieweg OE: Lymphoscintigraphy and intraoperative gamma probe detection of the first draining lymph node in clinically localized melanoma (abstract). Netherlands Cancer Institute, Netherlands. Society of Nuclear Medicine Annual Meeting, Minneapolis, MN, 1995
24. 24. Albertini J, Lyman G, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen D: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276, 22, 1818-1822, 1996
25. 25. Schneebaum S, Stadler J, Yaniv D, Baron J, Skornron Y: Gamma probe-guided sentinel node biopsy optimal timing for injection (abstract). Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Israel. San Antonio Breast Cancer Symposium, San Antonio, TX, 1995
26. 26. Albertini J, Milliotes G, Cruse CW, DeConti R, Rappaport D, Berman C, Glass LF, Fenske N, Reintgen D: Quality and cost outcome measurements in melanoma surgical care (abstract). H. L. Moffitt Cancer Center, University of South Florida. Society of Surgical Oncology, Boston, MA, 1995